STRATA Skin Sciences Inc (SSKN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
STRATA Skin Sciences Inc stock (SSKN) is currently trading at $0.28. STRATA Skin Sciences Inc PS ratio (Price-to-Sales) is 0.05. Analyst consensus price target for SSKN is $10.80. WallStSmart rates SSKN as Sell.
- SSKN PE ratio analysis and historical PE chart
- SSKN PS ratio (Price-to-Sales) history and trend
- SSKN intrinsic value — DCF, Graham Number, EPV models
- SSKN stock price prediction 2025 2026 2027 2028 2029 2030
- SSKN fair value vs current price
- SSKN insider transactions and insider buying
- Is SSKN undervalued or overvalued?
- STRATA Skin Sciences Inc financial analysis — revenue, earnings, cash flow
- SSKN Piotroski F-Score and Altman Z-Score
- SSKN analyst price target and Smart Rating
STRATA Skin Sciences Inc
📊 No data available
Try selecting a different time range
Smart Analysis
STRATA Skin Sciences Inc (SSKN) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
STRATA Skin Sciences Inc (SSKN) Key Strengths (3)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
Trading at 1.21x book value, attractively priced
Supporting Valuation Data
STRATA Skin Sciences Inc (SSKN) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -21.20%, a shrinking business
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Moderate institutional interest at 43.01%
Supporting Valuation Data
STRATA Skin Sciences Inc (SSKN) Detailed Analysis Report
Overall Assessment
This company scores 39/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 1.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Price/Book. Valuation metrics including PEG Ratio (0.03), Price/Sales (0.05), Price/Book (1.21) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -21.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -204.10%, Operating Margin at -26.80%, Profit Margin at -35.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -204.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -21.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SSKN Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SSKN's Price-to-Sales ratio of 0.05x trades at a deep discount to its historical average of 778.21x (2th percentile). The current valuation is 100% below its historical high of 6329.81x set in Nov 2009, and 24% above its historical low of 0.04x in Mar 2026. Over the past 12 months, the PS ratio has expanded from ~0.0x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for STRATA Skin Sciences Inc (SSKN) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
STRATA Skin Sciences Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 31M with 21% decline year-over-year. The company is currently unprofitable, posting a -35.1% profit margin.
Key Findings
Revenue contracted 21% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -35.1% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact STRATA Skin Sciences Inc.
Bottom Line
STRATA Skin Sciences Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About STRATA Skin Sciences Inc(SSKN)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
STRATA Skin Sciences, Inc., a medical technology company, develops, markets and markets products for the treatment of dermatological conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company is headquartered in Horsham, Pennsylvania.